116 related articles for article (PubMed ID: 26451872)
21. Kinetics of cyclocreatine and Na(+) cotransport in human breast cancer cells: mechanism of activity.
Maril N; Degani H; Rushkin E; Sherry AD; Cohn M
Am J Physiol; 1999 Oct; 277(4):C708-16. PubMed ID: 10516101
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of tumor necrosis factor-induced apoptosis in transgenic mouse liver expressing creatine kinase.
Hatano E; Tanaka A; Kanazawa A; Tsuyuki S; Tsunekawa S; Iwata S; Takahashi R; Chance B; Yamaoka Y
Liver Int; 2004 Aug; 24(4):384-93. PubMed ID: 15287863
[TBL] [Abstract][Full Text] [Related]
23. MR spectroscopy in heart failure--clinical and experimental findings.
Ten Hove M; Neubauer S
Heart Fail Rev; 2007 Mar; 12(1):48-57. PubMed ID: 17333358
[TBL] [Abstract][Full Text] [Related]
24. Cerebral creatine kinase deficiency influences metabolite levels and morphology in the mouse brain: a quantitative in vivo 1H and 31P magnetic resonance study.
in 't Zandt HJ; Renema WK; Streijger F; Jost C; Klomp DW; Oerlemans F; Van der Zee CE; Wieringa B; Heerschap A
J Neurochem; 2004 Sep; 90(6):1321-30. PubMed ID: 15341516
[TBL] [Abstract][Full Text] [Related]
25. Direct determination of creatine kinase equilibrium constants with creatine or cyclocreatine substrate.
LoPresti P; Cohn M
Biochim Biophys Acta; 1989 Oct; 998(3):317-20. PubMed ID: 2804134
[TBL] [Abstract][Full Text] [Related]
26. Relocation of truncated bid plays an important role in suppression of tumor necrosis factor alpha induced apoptosis in hepatocytes isolated from transgenic mouse.
Shiotani T; Yamanokuchi S; Hatano E; Ikai I
J Surg Res; 2005 Aug; 127(2):157-63. PubMed ID: 15882876
[TBL] [Abstract][Full Text] [Related]
27. NMR detection of creatine kinase expressed in liver of transgenic mice: determination of free ADP levels.
Koretsky AP; Brosnan MJ; Chen LH; Chen JD; Van Dyke T
Proc Natl Acad Sci U S A; 1990 Apr; 87(8):3112-6. PubMed ID: 2326269
[TBL] [Abstract][Full Text] [Related]
28. Gated dynamic 31P MRS shows reduced contractile phosphocreatine breakdown in mice deficient in cytosolic creatine kinase and adenylate kinase.
Kan HE; Veltien A; Arnts H; Nabuurs CI; Luijten B; de Haan A; Wieringa B; Heerschap A
NMR Biomed; 2009 Jun; 22(5):523-31. PubMed ID: 19156695
[TBL] [Abstract][Full Text] [Related]
29. Transgenic livers expressing mitochondrial and cytosolic CK: mitochondrial CK modulates free ADP levels.
Askenasy N; Koretsky AP
Am J Physiol Cell Physiol; 2002 Feb; 282(2):C338-46. PubMed ID: 11788345
[TBL] [Abstract][Full Text] [Related]
30. Antiproliferative effects of cyclocreatine on human prostatic carcinoma cells.
Hoosein NM; Martin KJ; Abdul M; Logothetis CJ; Kaddurah-Daouk R
Anticancer Res; 1995; 15(4):1339-42. PubMed ID: 7654018
[TBL] [Abstract][Full Text] [Related]
31. The synthetic phosphagen cyclocreatine phosphate inhibits the growth of a broad spectrum of solid tumors.
Schimmel L; Khandekar VS; Martin KJ; Riera T; Honan C; Shaw DG; Kaddurah-Daouk R
Anticancer Res; 1996; 16(1):375-80. PubMed ID: 8615639
[TBL] [Abstract][Full Text] [Related]
32. The utilisation of creatine and its analogues by cytosolic and mitochondrial creatine kinase.
Boehm EA; Radda GK; Tomlin H; Clark JF
Biochim Biophys Acta; 1996 Jun; 1274(3):119-28. PubMed ID: 8664304
[TBL] [Abstract][Full Text] [Related]
33. Presence of (phospho)creatine in developing and adult skeletal muscle of mice without mitochondrial and cytosolic muscle creatine kinase isoforms.
in 't Zandt HJ; de Groof AJ; Renema WK; Oerlemans FT; Klomp DW; Wieringa B; Heerschap A
J Physiol; 2003 May; 548(Pt 3):847-58. PubMed ID: 12640020
[TBL] [Abstract][Full Text] [Related]
34. Creatine kinase-catalyzed reaction rate in the cyanide-poisoned mouse brain.
Holtzman D; Offutt M; Tsuji M; Neuringer LJ; Jacobs D
J Cereb Blood Flow Metab; 1993 Jan; 13(1):153-61. PubMed ID: 8417004
[TBL] [Abstract][Full Text] [Related]
35. Synergistic effect on cardiac energetics by targeting the creatine kinase system: in vivo application of high-resolution
Maguire ML; McAndrew DJ; Lake HA; Ostrowski PJ; Zervou S; Neubauer S; Lygate CA; Schneider JE
J Cardiovasc Magn Reson; 2023 Feb; 25(1):6. PubMed ID: 36740688
[TBL] [Abstract][Full Text] [Related]
36. Creatine and cyclocreatine attenuate MPTP neurotoxicity.
Matthews RT; Ferrante RJ; Klivenyi P; Yang L; Klein AM; Mueller G; Kaddurah-Daouk R; Beal MF
Exp Neurol; 1999 May; 157(1):142-9. PubMed ID: 10222117
[TBL] [Abstract][Full Text] [Related]
37. In vivo detection of gene expression in liver by 31P nuclear magnetic resonance spectroscopy employing creatine kinase as a marker gene.
Auricchio A; Zhou R; Wilson JM; Glickson JD
Proc Natl Acad Sci U S A; 2001 Apr; 98(9):5205-10. PubMed ID: 11296261
[TBL] [Abstract][Full Text] [Related]
38. Quantitative liver 31P magnetic resonance spectroscopy at 3T on a clinical scanner.
Laufs A; Livingstone R; Nowotny B; Nowotny P; Wickrath F; Giani G; Bunke J; Roden M; Hwang JH
Magn Reson Med; 2014 May; 71(5):1670-5. PubMed ID: 23798380
[TBL] [Abstract][Full Text] [Related]
39. Altered brain phosphocreatine and ATP regulation when mitochondrial creatine kinase is absent.
Kekelidze T; Khait I; Togliatti A; Benzecry JM; Wieringa B; Holtzman D
J Neurosci Res; 2001 Dec; 66(5):866-72. PubMed ID: 11746413
[TBL] [Abstract][Full Text] [Related]
40. Specific targeting of tumor cells by the creatine analog cyclocreatine.
Martin K; Winslow E; Okeefe M; Khandekar V; Hamlin A; Lillie J; Kaddurahdaouk R
Int J Oncol; 1996 Nov; 9(5):993-9. PubMed ID: 21541606
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
